Sofinnova Investments, Inc. Novo Cure LTD Call Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	BUY	$56.44 - $118.81 $2.82 Million - $5.94 Million	50,000 New	50,000 $3.01 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $3.01 Million - $4.23 Million	-50,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $3.75 Million - $6.1 Million	50,000 New	50,000 $3.75 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.